Spots Global Cancer Trial Database for stage iii esophageal cancer
Every month we try and update this database with for stage iii esophageal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer | NCT00004236 | Esophageal Canc... Gastric Cancer | pegylated lipos... | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel | NCT00006245 | Esophageal Canc... | alvocidib paclitaxel | 18 Years - | National Cancer Institute (NCI) | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer | NCT00109850 | Esophageal Canc... | cetuximab cisplatin irinotecan hydr... radiation thera... | 18 Years - | SWOG Cancer Research Network | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | NCT00005638 | Esophageal Canc... Gastric Cancer | cisplatin irinotecan hydr... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery | NCT00258297 | Esophageal Canc... | gefitinib conventional su... enzyme inhibito... neoadjuvant the... protein tyrosin... surgery | 18 Years - | University of Rochester | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | NCT00002711 | Esophageal Canc... | chemotherapy cisplatin paclitaxel low-LET electro... low-LET photon ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer | NCT00002951 | Esophageal Canc... Head and Neck C... | fluorouracil hydroxyurea surgical proced... radiation thera... | - | University of Chicago | |
| Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery | NCT00445861 | Esophageal Canc... | cetuximab + doc... Treatment level... Treatment level... conventional su... | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
| Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery | NCT00011960 | Esophageal Canc... Gastric Cancer | cisplatin paclitaxel adjuvant therap... radiation thera... | - | Radiation Therapy Oncology Group | |
| Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00022139 | Esophageal Canc... Gastric Cancer | carboplatin fluorouracil paclitaxel conventional su... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer | NCT00628368 | Colorectal Canc... Esophageal Canc... | gene expression... mutation analys... polymorphism an... laboratory biom... biopsy endoscopic biop... | 18 Years - | National Cancer Institute (NCI) | |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer | NCT00025532 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | iodine I 131 mo... | 19 Years - | University of California, San Francisco | |
| Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00061958 | Adenocarcinoma ... Stage III Esoph... Stage IV Esopha... | arsenic trioxid... | 18 Years - | National Cancer Institute (NCI) | |
| Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | NCT00003118 | Esophageal Canc... | cisplatin fluorouracil surgical proced... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| DX-8951f in Treating Patients With Metastatic Stomach Cancer | NCT00017212 | Esophageal Canc... Gastric Cancer | exatecan mesyla... | 18 Years - | Daiichi Sankyo | |
| Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery | NCT00493025 | Esophageal Canc... | cisplatin gefitinib paclitaxel adjuvant therap... radiation thera... | 18 Years - 80 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach | NCT00004235 | Esophageal Canc... Gastric Cancer | docetaxel irinotecan hydr... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | NCT00003125 | Breast Cancer Esophageal Canc... Gastric Cancer Lung Cancer Pancreatic Canc... Unspecified Adu... | ALVAC-CEA vacci... aldesleukin sargramostim vaccinia-CEA va... | 18 Years - | Georgetown University | |
| Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery | NCT00416858 | Esophageal Canc... | cisplatin fluorouracil adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - | Federation Francophone de Cancerologie Digestive | |
| Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus | NCT00003087 | Esophageal Canc... | cisplatin paclitaxel surgical proced... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer | NCT00253708 | Cancer | management of t... massage therapy pain therapy psychosocial as... quality-of-life... | 18 Years - 120 Years | Beth Israel Deaconess Medical Center | |
| A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer | NCT00064259 | Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Esoph... Recurrent Gastr... Squamous Cell C... Stage III Esoph... Stage IIIA Gast... Stage IIIB Gast... Stage IIIC Gast... Stage IV Esopha... Stage IV Gastri... | oblimersen sodi... cisplatin fluorouracil | 19 Years - | National Cancer Institute (NCI) | |
| A Study of Creatine Combined With Curcumin in the Intervention of Early Cachexia in Upper Gastrointestinal Tumors | NCT05856500 | Stage IV Gastri... Stage IIIA Gast... Stage IIIB Gast... Stage III Esoph... Stage IV Esopha... | basic nutrition oral supplement... | 18 Years - 80 Years | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery | NCT00316862 | Esophageal Canc... | cisplatin irinotecan hydr... therapeutic con... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer | NCT03708042 | Stage II Esopha... Stage III Esoph... | Definitive Radi... Neoadjuvant Rad... | 18 Years - 70 Years | Tianjin Medical University Cancer Institute and Hospital | |
| LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer | NCT00010270 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | LMB-9 immunotox... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
| Irinotecan and Capecitabine in Treating Patients With Solid Tumors | NCT00003867 | Cancer | capecitabine irinotecan hydr... | 18 Years - 120 Years | Montefiore Medical Center | |
| Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery | NCT00238407 | Esophageal Canc... | Docetaxel and C... Radiotherapy | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
| Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00022139 | Esophageal Canc... Gastric Cancer | carboplatin fluorouracil paclitaxel conventional su... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery | NCT00493025 | Esophageal Canc... | cisplatin gefitinib paclitaxel adjuvant therap... radiation thera... | 18 Years - 80 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus | NCT00003087 | Esophageal Canc... | cisplatin paclitaxel surgical proced... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach | NCT00601705 | Esophageal Canc... Gastric Cancer | cisplatin epirubicin hydr... fluorouracil oxaliplatin adjuvant therap... neoadjuvant the... | 18 Years - | Case Comprehensive Cancer Center | |
| Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer | NCT00985192 | Esophageal Canc... Gastric Cancer | everolimus laboratory biom... | 18 Years - | Translational Oncology Research International | |
| Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus | NCT00003192 | Esophageal Canc... Gastric Cancer | aminocamptothec... | 18 Years - | University of Chicago | |
| Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer | NCT00093652 | Esophageal Canc... | gefitinib oxaliplatin conventional su... neoadjuvant the... radiation thera... | 18 Years - 120 Years | Roswell Park Cancer Institute | |
| Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer | NCT00711412 | Esophageal Canc... | Induction Thera... Induction Thera... Combination The... Combination The... Combination The... Evaluation for ... | 18 Years - 120 Years | Northwestern University | |
| Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer | NCT00006038 | Esophageal Canc... Gastric Cancer | cisplatin docetaxel floxuridine fluorouracil leucovorin calc... conventional su... | - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus | NCT00030862 | Esophageal Canc... | cisplatin irinotecan hydr... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer | NCT00064259 | Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Esoph... Recurrent Gastr... Squamous Cell C... Stage III Esoph... Stage IIIA Gast... Stage IIIB Gast... Stage IIIC Gast... Stage IV Esopha... Stage IV Gastri... | oblimersen sodi... cisplatin fluorouracil | 19 Years - | National Cancer Institute (NCI) | |
| Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer | NCT00963092 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer | DNA analysis RNA analysis microarray anal... protein analysi... cytology specim... laboratory biom... questionnaire a... | 16 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus | NCT00002984 | Esophageal Canc... | cisplatin fluorouracil paclitaxel surgical proced... radiation thera... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | NCT00006472 | Esophageal Canc... | carboplatin fluorouracil paclitaxel conventional su... radiation thera... | - 120 Years | Medstar Health Research Institute | |
| Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura | NCT00019825 | Esophageal Canc... Lung Cancer Malignant Mesot... Metastatic Canc... | decitabine | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery | NCT00290719 | Esophageal Canc... | cisplatin gefitinib irinotecan hydr... conventional su... neoadjuvant the... radiation thera... | 18 Years - | University of California, San Francisco | |
| A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal Cancer | NCT02959385 | Stage II Esopha... Stage III Esoph... | Definitive Radi... Neoadjuvant Rad... | 18 Years - 70 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction | NCT00891878 | Adenocarcinoma ... Esophageal Canc... | capecitabine sunitinib malat... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus | NCT00016900 | Esophageal Canc... | liposomal pacli... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer | NCT00006081 | Esophageal Canc... Gastric Cancer | Bryostatin-1 Paclitaxel (Tax... | 18 Years - | M.D. Anderson Cancer Center | |
| Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer | NCT00072033 | Esophageal Canc... | Cisplatin and D... | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | NCT00021320 | Esophageal Canc... | cisplatin fluorouracil paclitaxel conventional su... neoadjuvant the... radiation thera... | 18 Years - | Fox Chase Cancer Center | |
| Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer | NCT00601692 | Esophageal Canc... | cisplatin docetaxel irinotecan hydr... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer | NCT00040859 | Esophageal Canc... Gastric Cancer | capecitabine oxaliplatin | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer | NCT00004236 | Esophageal Canc... Gastric Cancer | pegylated lipos... | 18 Years - | National Cancer Institute (NCI) | |
| Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer | NCT00470184 | Esophageal Canc... | capecitabine oxaliplatin gene expression... microarray anal... reverse transcr... adjuvant therap... biopsy conventional su... neoadjuvant the... quality-of-life... radiation thera... | 18 Years - | Roswell Park Cancer Institute | |
| Irinotecan and Capecitabine in Treating Patients With Solid Tumors | NCT00003867 | Cancer | capecitabine irinotecan hydr... | 18 Years - 120 Years | Montefiore Medical Center | |
| Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus | NCT00008047 | Esophageal Canc... | fluorouracil hydroxyurea paclitaxel conventional su... radiation thera... | 18 Years - 80 Years | National Cancer Institute (NCI) | |
| Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer | NCT00004257 | Esophageal Canc... | fluorouracil oxaliplatin conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery | NCT00268437 | Esophageal Canc... | carboplatin Pemetrexed conventional su... neoadjuvant the... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus | NCT00002897 | Esophageal Canc... | cisplatin fluorouracil conventional su... | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer | NCT00072033 | Esophageal Canc... | Cisplatin and D... | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | NCT00002711 | Esophageal Canc... | chemotherapy cisplatin paclitaxel low-LET electro... low-LET photon ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach | NCT00601705 | Esophageal Canc... Gastric Cancer | cisplatin epirubicin hydr... fluorouracil oxaliplatin adjuvant therap... neoadjuvant the... | 18 Years - | Case Comprehensive Cancer Center | |
| Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors | NCT01172028 | Breast Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Lung Cancer Ovarian Cancer Prostate Cancer | Taxotere (Docet... Alimta (Pemetre... | 18 Years - | University of Arizona | |
| Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00061958 | Adenocarcinoma ... Stage III Esoph... Stage IV Esopha... | arsenic trioxid... | 18 Years - | National Cancer Institute (NCI) | |
| S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer | NCT00109850 | Esophageal Canc... | cetuximab cisplatin irinotecan hydr... radiation thera... | 18 Years - | SWOG Cancer Research Network | |
| S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction | NCT00086996 | Esophageal Canc... | fluorouracil oxaliplatin conventional su... radiation thera... | 18 Years - | SWOG Cancer Research Network | |
| Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00732745 | Adenocarcinoma ... Esophageal Canc... | docetaxel oxaliplatin vandetanib placebo | 18 Years - | Case Comprehensive Cancer Center | |
| Irinotecan in Treating Patients With Esophageal or Stomach Cancer | NCT00003748 | Esophageal Canc... Gastric Cancer | irinotecan hydr... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00069953 | Esophageal Canc... | filgrastim pegfilgrastim cisplatin fluorouracil paclitaxel conventional su... radiation thera... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus | NCT00003321 | Esophageal Canc... | psychosocial as... quality-of-life... | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery | NCT00416858 | Esophageal Canc... | cisplatin fluorouracil adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - | Federation Francophone de Cancerologie Digestive | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer | NCT00281788 | Esophageal Canc... | capecitabine carboplatin paclitaxel radiation thera... | 18 Years - | Duke University | |
| Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer | NCT00963092 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer | DNA analysis RNA analysis microarray anal... protein analysi... cytology specim... laboratory biom... questionnaire a... | 16 Years - | National Cancer Institute (NCI) | |
| S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction | NCT00086996 | Esophageal Canc... | fluorouracil oxaliplatin conventional su... radiation thera... | 18 Years - | SWOG Cancer Research Network | |
| Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer | NCT00354679 | Esophageal Canc... | bevacizumab cisplatin irinotecan hydr... proteomic profi... diagnostic labo... mass spectromet... adjuvant therap... neoadjuvant the... therapeutic con... radiation thera... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00022139 | Esophageal Canc... Gastric Cancer | carboplatin fluorouracil paclitaxel conventional su... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
